// App-Quantinova.ai

2150 : Association Of Health Care Expenditure With Results Of Allogeneic HSCT For Adults With ALL: An Analysis From Acute Leukemia Working Party Of The EBMT

Researchers

Presenter

  • Sebastian Giebel

Principal Investigators

  • Myriam Labopin

  • Adalberto Ibatici

  • Grant McQuaker

  • Dietrich Beelen

  • Noel Milpied

  • Antonio Campos

  • Charles Craddock

  • Mohamad Mohty

  • Paul Browne

  • Tomasz Czerw

  • Gerard Socie

  • Ali Unal

  • Slawomira Kyrcz-Krzemien

  • Andrea Bacigalupo

  • Hakan Goker

  • Michael Potter

Medical Centers

  • Trinity College Dublin and St. James's Hospital, Dublin, Ireland

  • Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Gliwice Branch, Gliwice, Poland

  • Centre for Clinical Haematology, Queen Elizabeth Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom

  • Department of Stem Cell Transplantation, University of Essen, Essen, Germany,

  • Glasgow Royal Infirmary, Glasgow, United Kingdom

  • EBMT Acute Leukemia Working Party and Registry, Hospital Saint-Antoine, Paris University, Paris, France

  • Inst. Portugues Oncologia, Porto, Portugal

  • The Royal Marsden Hospital, London, United Kingdom

  • Haematology II, Ospedale San Martino , Genova,

  • Erciyes University Hospital, Kayseri, Turkey

  • Ospedale San Martino, Genova, Italy.

  • Hematology Department, Hacettepe University Medical School, Ankara, Turkey

  • Hopital Saint-Louis, AP-HP, Universite Paris , Paris, France

  • University Hospital of Bordeaux, Bordeaux, France

  • department of hematology and cell therapy, hopital Saint-Antoine, EBMT Acute Leukemia Working Party and Registry, Hospital Saint-Antoine, Paris University, Paris, France

Locations

  • Ireland

  • Italy

  • Poland

  • Germany

  • Turkey

  • United Kingdom

  • Portugal

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Acute lymphoblastic leukemia

  • Acute Leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved